Light Street Capital Management, LLC / REGN
Light Street Capital Management, LLC’s Regeneron Pharmaceuticals Position
Does Light Street Capital Management, LLC own Regeneron Pharmaceuticals (REGN)? Not currently — the last reported position was 52.1K shares worth $25M in Q1 2020; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$25M
Q1 2020
Shares
52.1K
% of Portfolio
+1.34%
Quarters Held
1
position exited
Position History REGN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2020 | 52.1K | $25M | +1.34% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Light Street Capital Management, LLC’s full portfolio or all institutional holders of REGN.